Company intelligence / Profile preview

Generi Biotech

Hradec Králové, Czech Republic

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Generi Biotech is a Czech biotechnology company specializing in the development and manufacture of molecular diagnostic kits and the provision of specialized R&D services. Founded in 1995, the company focuses on PCR-based diagnostics for oncology, hematology, and infectious diseases, as well as the custom synthesis of oligonucleotides. They offer a wide range of IVD-certified products and provide contract research services for the pharmaceutical and healthcare industries. The company is ISO 9001 and ISO 13485 certified, ensuring high standards for its laboratory and manufacturing processes.

Therapeutic areas: HematologyOtherInfectious DiseasesPulmonologyOncology
Modalities: OligonucleotidesDiagnostic kit
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Generi Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Generi Biotech.

Explore the full profile